Finance

Beta
Lists
DTC:FRA
Defence Therapeutics Inc
€0.34
+6.25%
(+0.020) 1D
May 29, 10:00:00 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for DTC...
Open
€0.28
High
€0.34
Low
€0.28
Mkt. cap
33.11M
Avg. vol.
6.22K
Volume
4.50K
52-wk high
€0.62
52-wk low
€0.26
Open
€0.28
High
€0.34
Low
€0.28
Mkt. cap
33.11M
Avg. vol.
6.22K
Volume
4.50K
52-wk high
€0.62
52-wk low
€0.26
News stories
From sources across the web
About Defence Therapeutics Inc
CEO-
Employees-
Founded2017
HeadquartersVancouver, British Columbia, Canada
SectorBiotechnology
Websitedefencetherapeutics.com
Previous reportsAll values in CAD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CAD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
335.23K
115.60K
316.51K
729.19K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
922.56K
353.71K
964.46K
401.52K
Operating expense
1.42M
599.46K
1.37M
1.16M
Total operating expenses
1.42M
599.46K
1.37M
1.16M
Operating income
-1.42M
-599.46K
-1.37M
-1.16M
Other non operating income
315.48K
-75.71K
-36.17K
-1.75M
EBT including unusual items
-1.16M
-703.00K
-1.52M
-2.96M
EBT excluding unusual items
-1.08M
-703.00K
-1.52M
-2.96M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-1.16M
-703.00K
-1.52M
-2.96M
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
-
-
631.00
-
Interest expense
-21.68K
-11.92K
-111.06K
-76.49K
Net interest expenses
-21.68K
-11.92K
-110.43K
-76.49K
Depreciation and amortization charges
19.21K
16.24K
9.28K
9.42K
EBITDA
-1.41M
-589.88K
-1.36M
-1.15M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer